January 19, 2018 β The U.S. Food and Drug Administration (FDA) announced that International Laboratories LLC is ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
January 19, 2018
January 16, 2018 β American College of Cardiology (ACC) Chief Executive Officer Shalom βShalβ Jacobovitz will be leaving ...
January 16, 2018
December 12, 2017 β Mayo Clinic researchers have shown a link between which type of oral anticoagulant a patient takes ...
December 12, 2017November 16, 2017 β Bristol-Myers Squibb Company and Pfizer Inc. released real-world data (RWD) of outcomes associated ...
November 16, 2017November 10, 2017 β Moderna Therapeutics announced a new license and collaboration with AstraZeneca to co-develop and co ...
November 13, 2017
November 6, 2017 β Β The first trial to evaluate the safety of dual antiplatelet therapy (DAPT) for less than 12 months ...
November 06, 2017
November 6, 2017 β Elderly patients undergoing percutaneous coronary intervention (PCI) often receive bare-metal stents ...
November 06, 2017
November 3, 2017 β A ten-year decline in the blood cholesterol of heart attack patients in Malaysia suggests statins are ...
November 03, 2017
November 1, 2017 β OrbusNeich reported results from the REDUCE trial in the Late-Breaking Clinical Trial session at the ...
November 01, 2017
October 27, 2017 β CeloNova BioSciences Inc. announced the U.S. Food and Drug Administration (FDA) approved expansion of ...
October 27, 2017October 24, 2017 β Roche and Ncardia have reached a broad licensing agreement whereby Roche and its affiliate companies ...
October 24, 2017
October 18, 2017 β Results from the pivotal Phase 3 COMPASS study found that the Xarelto vascular dose plus aspirin 100 ...
October 18, 2017October 4, 2017 β MyoKardia Inc. recently provided a clinical update on its MYK-491 program for dilated cardiomyopathy.
...
October 04, 2017
September 19, 2017 β The heart failure space across the seven key markets of the U.S., France, Germany, Italy, Spain ...
September 19, 2017September 12, 2017 β Inclisiran lowers low-density lipoprotein (LDL, or βbadβ) cholesterol for up to one year in ...
September 12, 2017Β© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now